apatinib
Ligand Summary
Apatinib is an oral tyrosine kinase inhibitor approved in China for the treatment of patients with advanced metastatic gastric cancer.
UNII: 5S371K6132
PubChem: 11315474
PubChem: 45139106
ChEMBL: CHEMBL3186534
ChEMBL: CHEMBL3545414
DrugCentral: 5211
LyCHI: 7797KZ99NH6L
Target Activities
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | INHIBITOR | |||||